LB Pharmaceuticals Inc Common Stock
NASDAQ:LBRXBiotechnology
-$0.39 today
- Market cap
- $1.30B
- Beta
- 0.71
- P/E (TTM)
- -21.4
- EPS (TTM)
- -$1.39
Volume 0.36M
Average 0.23M
Balance Sheet
Inspect the capital base behind the business.
Assets
$312.93M
FY 2025 · Annual
+833.2% YoYLiabilities
$11.62M
FY 2025 · Annual
-90.9% YoYEquity
$301.31M
FY 2025 · Annual
Balance Sheet
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $320.7M |
| Short-term Investments | $45.0M |
| Other Current | $23.4M |
| Total Current Assets | $389.1M |
| PP&E (Net) | $3.6M |
| Long-term Investments | $776.0K |
| Total Non-current Assets | $4.4M |
| Total Assets | $393.5M |
Analysis
Selected assets total $393.5M for Latest. The largest visible component is Cash & Equivalents at $320.7M, about 81.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | |
| 8-K | Current report | Nov 5, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 13, 2026 | |
| SC 13G/A | SC 13G/A filing | Oct 13, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 13, 2026 |
How much cash does LBRX have?
LB Pharmaceuticals Inc Common Stock (LBRX) reported $250.17M in cash and equivalents in fiscal 2025.
How much debt does LBRX carry?
LB Pharmaceuticals Inc Common Stock (LBRX) reported $3.57M of total debt, with net debt of -$246.60M.
Continue the stock analysis
Jump to another research area for this company.